Given that cancer-induced bone pain in our model is transduced by peripheral nociceptors in the dorsal root ganglion (DRG), we next sought to determine whether STING signaling in peripheral sensory neurons contributes to the antinociceptive effects of STING agonists in bone cancer pain. This evidence concerns the gene STING1 and bone neoplasm.